Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...
Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...
Worldcrunch on MSN7h
Leqembi, Is This New Drug The Turning Point In Curing Alzheimer’s?That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...
Researchers explain how a drug that helps patients with neurological issues walk may also provide a surprising boost for the ...
Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced ...
Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback